Health Care Innovation
Commentary
Drop ‘Bigger Subsidies’ Narrative for Better Insurance Options
The federal government is covering a smaller share of Obamacare enrollees’ premiums this year. That has Democrats warning of a surge in the number of uninsured, as people struggle to shoulder more of the cost themselves. But recent reporting on some of those losing their enhanced premium subsidies reveals that ...
Sally C. Pipes
February 17, 2026
Commentary
Arizona Republicans should stop trying to ban mRNA vaccines
Despite Democratic Governor Hobbs’ past efforts to expand Arizonans’ access to cutting-edge medicines, the state Legislature continues to propose harmful anti-mRNA bills. The latest example is House Bill 2332, which, if enacted, would deny Arizonans access to promising technologies that could cure cancer and minimize the health consequences from deadly ...
Sally Pipes and Wayne Winegarden
February 11, 2026
Commentary
Proposed Patent Tax Threatens the Research That Powers Growth
Is federally funded science really a raw deal for taxpayers? Commerce Secretary Howard Lutnick seems to think so. “If we fund it and they invent a patent,” he recently said, “the United States of America taxpayer should get half the benefit.” Lutnick is proposing a 50% excise tax on the ...
Sally C. Pipes
February 10, 2026
Commentary
Cancer Breakthroughs Threatened by D.C.’s Price Controls
Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in ...
Sally C. Pipes
February 6, 2026
Commentary
Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem
US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
Sally C. Pipes
January 26, 2026
Commentary
No Accountability as Insurers Profit From Public Programs
Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability. It’s about time. From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients ...
Sally C. Pipes
January 22, 2026
Commentary
Red tape is strangling rural health care. It’s time to cut it
Rural America is running out of doctors. According to a new report from the Commonwealth Fund, 43 million Americans now live in rural communities facing a shortage of primary care providers. This shortage isn’t new. It’s been reality for rural America for decades. And it helps explain why patients there ...
Sally C. Pipes
January 22, 2026
Commentary
California should embrace competition to promote better health insurance
Following a depressingly familiar pattern, California is once again undermining health care competition in the vain hope that less competition will lead to lower prices. It won’t. In its latest anti-competitive actions, starting Jan. 1, California’s Department of Health Care Services will be limiting competition for plans (called Medi-Medi plans) ...
Wayne H Winegarden
December 31, 2025
Commentary
Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients
Chaos has become the norm at the U.S. Food and Drug Administration. And it’s putting American patients, not to mention our country’s world-leading life sciences sector, at risk. Earlier this year, roughly 3,500 FDA employees were laid off. The agency’s Center for Drug Evaluation and Research, which oversees prescription and ...
Sally C. Pipes
December 15, 2025
Commentary
Democrats Can’t End Private-Sector Drug Innovation Fast Enough
In November, a group of Democrats in the U.S. House made clear that they’ll sacrifice medical innovation for lower drug prices if they ever reclaim Congress. Patients today and tomorrow will be the losers in that trade. Read the op-ed here.
Sally C. Pipes
December 15, 2025
Drop ‘Bigger Subsidies’ Narrative for Better Insurance Options
The federal government is covering a smaller share of Obamacare enrollees’ premiums this year. That has Democrats warning of a surge in the number of uninsured, as people struggle to shoulder more of the cost themselves. But recent reporting on some of those losing their enhanced premium subsidies reveals that ...
Arizona Republicans should stop trying to ban mRNA vaccines
Despite Democratic Governor Hobbs’ past efforts to expand Arizonans’ access to cutting-edge medicines, the state Legislature continues to propose harmful anti-mRNA bills. The latest example is House Bill 2332, which, if enacted, would deny Arizonans access to promising technologies that could cure cancer and minimize the health consequences from deadly ...
Proposed Patent Tax Threatens the Research That Powers Growth
Is federally funded science really a raw deal for taxpayers? Commerce Secretary Howard Lutnick seems to think so. “If we fund it and they invent a patent,” he recently said, “the United States of America taxpayer should get half the benefit.” Lutnick is proposing a 50% excise tax on the ...
Cancer Breakthroughs Threatened by D.C.’s Price Controls
Cancer survival rates are on the rise, according to the American Cancer Society’s latest annual report. Seven in 10 patients now live five years or more after a cancer diagnosis. Since 1991, reductions in smoking and improvements in disease management and earlier diagnosis have resulted in a 34% drop in ...
Proposed patent tax offers a dangerous ‘solution’ to a non-existent problem
US Commerce Secretary Howard Lutnick believes taxpayers are getting short-changed by America’s patent system. Last year, he argued that the federal government should be entitled to 50% of the revenue universities earn from licensing the patented discoveries they’ve made with help from federally funded research grants. Lutnick is deeply mistaken. ...
No Accountability as Insurers Profit From Public Programs
Executives from the nation’s largest health insurers are set to testify before Congress soon in a hearing on healthcare affordability. It’s about time. From Medicare Advantage to Obamacare exchanges to prescription drug benefits, insurers have been extracting ever-greater amounts of public funds while passing costs and risk on to patients ...
Red tape is strangling rural health care. It’s time to cut it
Rural America is running out of doctors. According to a new report from the Commonwealth Fund, 43 million Americans now live in rural communities facing a shortage of primary care providers. This shortage isn’t new. It’s been reality for rural America for decades. And it helps explain why patients there ...
California should embrace competition to promote better health insurance
Following a depressingly familiar pattern, California is once again undermining health care competition in the vain hope that less competition will lead to lower prices. It won’t. In its latest anti-competitive actions, starting Jan. 1, California’s Department of Health Care Services will be limiting competition for plans (called Medi-Medi plans) ...
Chaos At The FDA Benefits America’s Rivals—At The Expense Of America’s Patients
Chaos has become the norm at the U.S. Food and Drug Administration. And it’s putting American patients, not to mention our country’s world-leading life sciences sector, at risk. Earlier this year, roughly 3,500 FDA employees were laid off. The agency’s Center for Drug Evaluation and Research, which oversees prescription and ...
Democrats Can’t End Private-Sector Drug Innovation Fast Enough
In November, a group of Democrats in the U.S. House made clear that they’ll sacrifice medical innovation for lower drug prices if they ever reclaim Congress. Patients today and tomorrow will be the losers in that trade. Read the op-ed here.
